Vision Share Spotlights Moria's XTRA4: A Breakthrough in Corneal Preservation and Global Impact
illi News/10315719

CHICAGO - illiNews -- Vision Share, the largest non-profit network of EBAA accredited and FDA registered eye banks, recently sat down with Jana Tothova, Group Head of Research and Development and Elisa Valguarnera, Product Manager at Moria Surgical to discuss the company's newly FDA-cleared XTRA4™ corneal storage medium - a next-generation solution designed to extend corneal preservation and optimize tissue quality for transplantation.

"The formulation of XTRA4 reflects a deep understanding of corneal physiology," said Jana Tothova, PhD, Group Head of R&D at Moria Surgical. "By replacing dextran and rebalancing the medium, we've created an environment that keeps the cornea in a more natural state —reducing cell stress and maintaining viability and clarity over time."

Developed over years of dedicated research, XTRA4 replaces dextran with a different deswelling agent that better replicates physiological conditions within the cornea. This innovation allows for up to 14 days of storage at 2–8°C, maintaining tissue transparency and endothelial integrity while doubling the traditional preservation window. The FDA's recent 510(k) clearance marks a key milestone for U.S. eye banks and surgeons eager to access extended-life, high-quality tissue.

More on illi News

• UK Financial Ltd Announces A Special Board Meeting Today At 4PM: Orders MCAT Lock on CATEX, Adopts ERC-3643 Standard, & Cancels $0.20 MCOIN for $1
• 6 Holiday Looks That Scream "Old Money" But Cost Less Than Your Christmas Tree
• From Cheer to Courtroom: The Hidden Legal Risks in Your Holiday Eggnog
• JRP Virtual Celebrates Alexis Knapp as Former Talent Secures New Role in Upcoming Sci-Fi Film
• 2nd National Dual-Use Design Challenge for Agriculture + Solar Innovation

As an advocate for innovation in eye banking, Vision Share is spotlighting the XTRA4 development to advance conversations among clinicians, researchers, and partner eye banks worldwide. The organization continues to highlight technologies and collaborations that improve patient outcomes and expand equitable access to sight-restoring care.

The full interview with Moria's team is available on Vision Share's website: visionshare.org

About Vision Share

Vision Share is a 501(c)(3) nonprofit network of U.S. eye banks committed to advancing global sight restoration. Through its accredited member organizations, Vision Share provides safe, high-quality corneal tissue for transplantation and research, supports innovation in eye banking, and facilitates international collaboration. By connecting surgeons, researchers, and eye banks worldwide, Vision Share works to ensure that access to sight-saving tissue and technologies transcends borders.

Learn more at www.visionshare.org.